Corpus Intelligence IC Memo — CRENSHAW COMMUNITY HOSPITAL 2026-04-26 11:19 UTC
IC Memo — CRENSHAW COMMUNITY HOSPITAL
Investment Committee Memorandum | AL | 29 beds | Grade D | EBITDA uplift $626K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CRENSHAW COMMUNITY HOSPITAL

CCN 010008 | CRENSHAW, AL | 29 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CRENSHAW COMMUNITY HOSPITAL is a 29-bed under-performing / distressed in CRENSHAW, AL with $8.4M in net patient revenue and a -77.2% operating margin. The hospital serves a payer mix of 35.4% Medicare, 15.1% Medicaid, and 49.4% commercial.

Thesis: Turnaround. Our ML models identify $626K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -77.2% to -69.7% (+745bps).

Net Revenue HCRIS$8.4M
Current EBITDA COMPUTED$-6.5M
Operating Margin COMPUTED-77.2%
Occupancy HCRIS12.6%
Revenue / Bed COMPUTED$289K
Net-to-Gross HCRIS22.8%
Distress Probability ML60.1%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
56
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -77.2% places it below the state median. Among 56 size-comparable peers (14-58 beds), the median margin is -14.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (14-58), prioritizing same-state peers. 56 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CRENSHAW COMMUNITY HOSPITAL (Target)AL29$8.4M-77.2%
RUSSELL MEDICAL CENTERAL45$75.3M-14.8%
JACK HUGHSTON MEMORIAL HOSPITAAL47$75.2M6.5%
NORTH BALDWIN INFIRMARYAL35$55.3M-3.3%
PRATTVILLE BAPTIST HOSPITALAL55$53.5M-16.2%
HIGHLANDS MEDICAL CENTERAL45$45.9M-30.2%
ST. VINCENTS ST. CLAIRAL40$40.8M8.7%
TROY REGIONAL MEDICAL CENTERAL41$39.0M-9.1%
WHITFIELD REGIONAL HOSPITALAL47$38.7M-21.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $626K (745bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$176K+210bp18mo
Denial Rate Reduction12.0%6.5%$170K+202bp12mo
Cost to Collect4.5%2.5%$168K+200bp12mo
A/R Days Reduction5200.0%3800.0%$102K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+11bp6mo

5. EBITDA Bridge

Net Collection Rate
$176K
Denial Rate Reduction
$170K
Cost to Collect
$168K
A/R Days Reduction
$102K
Clean Claim Rate
$10K
Total EBITDA Uplift$626K
Current EBITDA$-6.5M
+ RCM Uplift+$626K
Pro Forma EBITDA$-5.9M
Current Margin-77.2%
Pro Forma Margin-69.7%
WC Released (1x)$322K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-10.0M$-36.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-10.0M$-43.4M0.00x-100.0%
Bull Case9.0x11.0x$-9.0M$-44.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-9.0M$-51.2M0.00x-100.0%
Bear Case11.0x10.0x$-11.0M$-36.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-11.0M$-43.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 12.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 60.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 56 hospitals with 14-58 beds
  • Same-state prioritization (n=57)
  • Comp margins: P25=-25.6% / P50=-14.8% / P75=-2.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.